Stock Events

Stock Events

Argent Biopharma 

$0.03
59
+$0+0% Wednesday 20:00

Statistics

Day High
0.03
Day Low
0.03
52W High
0.15
52W Low
0.01
Volume
10,000
Avg. Volume
2,441
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

27FebExpected
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-20.86
-20.53
-20.19
-19.86
Expected EPS
N/A
Actual EPS
N/A

Financials

-1,283.28%Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
892,433.97Revenue
-11.45MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RGTLF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes in various therapeutic areas, including those Argent Biopharma is involved in.
Merck
MRK
Mkt Cap214.76B
Merck operates in similar therapeutic areas as Argent Biopharma, making them direct competitors in the pharmaceutical industry.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, competes with Argent Biopharma in developing treatments for various diseases.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes in the biopharmaceutical field, focusing on areas like immunology and oncology, which may overlap with Argent Biopharma's interests.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that develops innovative therapeutics, potentially in competition with Argent Biopharma's product pipeline.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is involved in discovering, developing, and delivering innovative medicines that could compete with Argent Biopharma's offerings.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that focuses on areas such as infectious diseases, where Argent Biopharma may also be active.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that operates in various therapeutic areas, potentially competing with Argent Biopharma.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG, through its pharmaceuticals and diagnostics divisions, competes in the development of innovative healthcare solutions.
Sanofi
SNY
Mkt Cap124.45B
Sanofi is a global biopharmaceutical company focusing on human health, directly competing with Argent Biopharma in several therapeutic areas.

About

Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company's principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer's. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and R&D, which focuses on wound treatment. The company has collaborated with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Show more...
CEO
Mr. Roby Reuven Zomer
Country
GB
ISIN
AU0000326647

Listings

OTC Link
US
RGTLF
F
DE
H5O0.F
AU
AU
RGT.AU

0 Comments

Share your thoughts

FAQ

What is Argent Biopharma stock price today?▼
The current price of RGTLF is $0.03 USD — it has increased by +0% in the past 24 hours. Watch Argent Biopharma stock price performance more closely on the chart.
What is Argent Biopharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Argent Biopharma stocks are traded under the ticker RGTLF.
When is the next Argent Biopharma earnings date?▼
Argent Biopharma is going to release the next earnings report on August 28, 2026.
What is Argent Biopharma revenue for the last year?▼
Argent Biopharma revenue for the last year amounts to 892,433.97 USD.
What is Argent Biopharma net income for the last year?▼
RGTLF net income for the last year is -11.45M USD.
When did Argent Biopharma complete a stock split?▼
The last stock split for Argent Biopharma was on October 30, 2023 with a ratio of 1:1000.
Where is Argent Biopharma headquartered?▼
Argent Biopharma is headquartered in Subiaco, GB.